General Information of Drug Inactive Ingredient (DIG) (ID: E00383)

DIG Name
Isomalt
Synonyms
Isomalt; 1-O-alpha-D-Glucopyranosyl-D-mannitol; Palatinit; 20942-99-8; 64519-82-0; UNII-G97P6S66E9; G97P6S66E9; D-Mannitol, 1-O-alpha-D-glucopyranosyl-; (2R,3R,4R,5R)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,4,5-pentol; Isomaltidex; GalenIQ 980; a-D-Glcp-1,1-D-Mannitol; 1-o-d-glucopyranosyl-d-mannitol; CCRIS 3698; 1-O-beta-D-glucopyranosyl-D-mannitol; HSDB 7969; DSSTox_CID_753; DSSTox_RID_75770; DSSTox_GSID_20753; SCHEMBL154031; CHEMBL3187473; DTXSID60872321; CHEBI:150326; 6-O-a-D-Glucopyranosyl-D-glucitol; GPM; EINECS 244-122-4; Tox21_200914; MFCD03414194; ZINC31319586; NCGC00248874-01; NCGC00258468-01; CAS-64519-82-0; A14329; Q412068; W-109182; 570FC73A-80F5-464F-B47E-B9B4CC544121; UNII-3A0A6EFR5I component SERLAGPUMNYUCK-DCUALPFSSA-N; WURCS=2.0/2,2,1/[h1122h][a2122h-1a_1-5]/1-2/a6-b1; D-Glucitol, 6-O-alpha-D-glucopyranosyl-, mixed with 1-O-alpha-D-glucopyranosyl-D-mannitol; D-Glucitol, 6-O-alpha-D-glucopyranosyl-, mixt. with 1-O-alpha-D-glucopyranosyl-D-mannitol; (2R,3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol; (2R,3R,4R,5R)-6-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)hexane-1,2,3,4,5-pentaol
DIG Function
Binding agent; Coating agent; Diluent; Flavoring agent; Suspending agent
Formula
C12H24O11
Canonical SMILES
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O)O)O
InChI
1S/C12H24O11/c13-1-4(15)7(17)8(18)5(16)3-22-12-11(21)10(20)9(19)6(2-14)23-12/h4-21H,1-3H2/t4-,5-,6-,7-,8-,9-,10+,11-,12+/m1/s1
InChIKey
SERLAGPUMNYUCK-DCUALPFSSA-N
Physicochemical Properties Molecular Weight 344.31 Topological Polar Surface Area 201
XlogP -5.2 Complexity 343
Heavy Atom Count 23 Rotatable Bond Count 8
Hydrogen Bond Donor Count 9 Hydrogen Bond Acceptor Count 11

Full List of Drug(s) Co-administrated with This DIG

3 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Lamivudine DMI347A Chronic HBV infection [1E51.0Z] Lamivudine 100 mg tablet F11031
Risdiplam DMIMF8J Spinal muscular atrophy [8B61] Risdiplam 0.75 mg/ml powder F23278
Ingrezza DMVPLNC Tardive dyskinesia [8A02.10] Valbenazine 80 mg capsule F21829
------------------